Evidence map›Paper›PMID 28836544›Full record

Observational studyChinese medical journal2017

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.

Ying Peng, Song-Hua Chen, Le Zhang, Bin Chen, Ming-Wu Zhang, Tie-Niu He, Fei Wang, Cheng-Liang Chai, Lin Zhou, Yu Zhang and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Chinese medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Multi-drug resistantAfrican journal of laboratory medicine · 2018
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ying PengZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Song-Hua ChenZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Le ZhangNational Institute of Drug Dependence; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
Bin ChenZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Ming-Wu ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Tie-Niu HeZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Fei WangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Cheng-Liang ChaiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Lin ZhouZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Yu ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Xiao-Meng WangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China.
Zhongwei JiaNational Institute of Drug Dependence, Peking University, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScreening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious TB subpopulations excluding the new TB patients. This study aimed to examine MDR-TB burden among the new TB patients.

methodsWe conducted a study in Zhejiang Province during 2009-2013 to screen for MDR-TB patients among the low MDR-TB risk patients and five subpopulations of high MDR-TB risk patients. The number, prevalence, and trend of MDR-TB were compared while the logistic regression model was used to examine risk factors related to MDR-TB.

resultsA total of 200 and 791 MDR-TB cases were, respectively, identified from the 9830 new TB cases and 2372 high-risk suspects who took MDR-TB screening from 2009 to 2013. The MDR-TB rates went down in both of the new TB patients and five MDR-TB high-risk groups over the study time, but the percentage of MDR-TB patients identified from the new TB patients in all diagnosed MDR-TB cases kept stable from 28.3% in 2011 to 27.0% in 2012 to 26.0% in 2013.

conclusionsThe study indicated that MDR-TB burden among new TB patients was high, thus screening for MDR-TB among the new TB patients should be recommended in China as well as in the similar situation worldwide.

Indexed as

AdolescentAdultAntitubercular AgentsChildChild, PreschoolChinaFemaleHumansInfantInfant, NewbornLogistic ModelsMaleMiddle AgedPrevalenceRisk FactorsTuberculosisAntitubercular Agents

Identifiers

PMID28836544
PMCPMC5586168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.